Grey Matters Health (CSE:GREY, OTCQB:AGNPD, FRA:AGW0) said it has amended the warrant terms of its non-brokered private placement, removing the acceleration feature and extending the warrant exercise period to three years.
The company is seeking gross proceeds of C$1M through the sale of units priced at C$0.40 each, with every unit consisting of one common share and one warrant exercisable at C$0.60 per share for 36 months.
Proceeds will support its Alzheimer’s disease program, including plans for a first US brain-specific neuroimaging clinic, as well as working capital and general expenses.